Life sciences firms' likelihood of locating manufacturing facilities in the U.S. 2018

Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

October 2018

Region

Worldwide, United States

Survey time period

summer 2018

Number of respondents

60 executives

Special properties

30 from biopharma, 30 from medtech

Supplementary notes

Original question: "Has U.S. tax reform increased or decreased the likelihood your company will move existing manufacturing facilities back to the United States or locate a new manufacturing facilities in the United States?"

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

7

Other regions

10

Related statistics

10

Further related statistics

10
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.